Editor's Summaries of the Articles Published in This Issue of Molecular Medicine Communications
Clicks: 106
ID: 275537
2022
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.0
/100
20 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In this issue, Riaz et al., carried out a pharmacological investigation of Carvacrol against D-galactose-induced cognitive impairment in mice, Fawad and Tahir reviewed the existing and emerging therapies in amyotrophic lateral sclerosis, Jahan and colleagues did a comparative analysis of the hepatoprotective potential of Co-enzyme Q10 as a preventive and therapeutic agent in statin-induced hepatotoxicity, Sheikh et al., reviewed studies with angiotensin-converting enzyme (ACE) inhibitors; their efficacy, adverse effects, and the genetic influence on ACE inhibitors induced cough.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (78 words).
Try re-searching for a better abstract.
| Reference Key |
staff2022moleculareditor's
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Editorial Staff; |
| Journal | Molecular Medicine Communications |
| Year | 2022 |
| DOI |
83
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.